THB: Join our mission to radically transform health benefits™

THB Advisor | 2021 | Episode 4 | Replay

THB Advisor | 2021 | Episode 4 | Replay

Webinars - Advisors

THB Advisor | 2021 | Episode 4 | Replay

Prescription Drugs: The Single Fastest Way To Get Control Of Your Health Benefits Spend

Thursday, April 8, 2021, 2:00 PM ET

Prescription drugs – Rx – is the quickest growing sector of your health benefits spend, and the one you understand the least. Why is that?  Here are some facts that might surprise you:

  • The US spends over $355B in Rx cost annually; the largest spend in the world
  • 1-3% of plan members represent over 50% of total drug costs
  • 1 in 4 people in the US has difficulty paying the cost of their prescription medications; those who reported having the greatest difficulty affording their prescription drugs were those who most needed them, including those who took 4 or more prescription drugs, spent $100 or more per month on their drugs, and reported being in fair or poor health
  • Most of these people would qualify for some sort of patient assistance

In this webinar, you’ll learn:

  • How to immediately impact total Rx spend by more than 30%
  • What characteristics, questions, and expectations you should have regarding your Rx partners (PBMs)
  • How to instantly cut speciality spend in half, while eliminating cost for both employees and their families

Meet The Panelists

Rachel Strauss

Rachel Strauss

Director of Strategic Development at EHIM

Nicole Elover

Nicole Elover

National Sales Executive at Script Sourcing

Watch The Replay

5.0
5.0 out of 5 stars (based on 3 reviews)
Excellent100%
Very good0%
Average0%
Poor0%
Terrible0%

You Can Also…

Be A Part of the Series

Complete the brief form below to invite your clients and prospects to the upcoming employer version of this webinar. We’ll send you an email over the coming days with instructions on how to get an invitation out to your network. It’s a great way to establish yourself as a leader in the marketplace and to grow your authority on a wide array of leading topics.

Viewer Reviews

There are no reviews yet. Be the first one to write one.

Leave Your Review